258 related articles for article (PubMed ID: 18676095)
21. Accelerated whole breast irradiation in early breast cancer patients with adverse prognostic features.
Lee SW; Shin KH; Chie EK; Kim JH; Im SA; Han W; Noh DY; Lim HW; Kim TH; Lee KS; Lee ES; Sung SY; Kim K
Oncotarget; 2016 Dec; 7(49):81888-81898. PubMed ID: 27588485
[TBL] [Abstract][Full Text] [Related]
22. Interim cosmetic results and toxicity using 3D conformal external beam radiotherapy to deliver accelerated partial breast irradiation in patients with early-stage breast cancer treated with breast-conserving therapy.
Vicini FA; Chen P; Wallace M; Mitchell C; Hasan Y; Grills I; Kestin L; Schell S; Goldstein NS; Kunzman J; Gilbert S; Martinez A
Int J Radiat Oncol Biol Phys; 2007 Nov; 69(4):1124-30. PubMed ID: 17967306
[TBL] [Abstract][Full Text] [Related]
23. Long-term outcome and toxicity in a Phase I/II trial using high-dose-rate multicatheter interstitial brachytherapy for T1/T2 breast cancer.
Kaufman SA; DiPetrillo TA; Price LL; Midle JB; Wazer DE
Brachytherapy; 2007; 6(4):286-92. PubMed ID: 17991625
[TBL] [Abstract][Full Text] [Related]
24. Phase I-II trial of prone accelerated intensity modulated radiation therapy to the breast to optimally spare normal tissue.
Formenti SC; Gidea-Addeo D; Goldberg JD; Roses DF; Guth A; Rosenstein BS; DeWyngaert KJ
J Clin Oncol; 2007 Jun; 25(16):2236-42. PubMed ID: 17470849
[TBL] [Abstract][Full Text] [Related]
25. Simultaneous-integrated boost intensity-modulated radiation therapy (SIB-IMRT) in the treatment of early-stage left-sided breast carcinoma.
Singla R; King S; Albuquerque K; Creech S; Dogan N
Med Dosim; 2006; 31(3):190-6. PubMed ID: 16905449
[TBL] [Abstract][Full Text] [Related]
26. Pilot study of sole conformal peroperative interstitial brachyradiotherapy of early stage breast carcinoma using high-dose rate afterloading.
Slampa P; Soumarova R; Ruzickova J; Chrenko V; Fait V; Bartlova R; Ticha H; Zaloudik J
Neoplasma; 2005; 52(4):292-6. PubMed ID: 16059644
[TBL] [Abstract][Full Text] [Related]
27. Comparative acute toxicity from whole breast irradiation using 3-week accelerated schedule with concomitant boost and the 6.5-week conventional schedule with sequential boost for early-stage breast cancer.
Chadha M; Vongtama D; Friedmann P; Parris C; Boolbol SK; Woode R; Harrison LB
Clin Breast Cancer; 2012 Feb; 12(1):57-62. PubMed ID: 22056970
[TBL] [Abstract][Full Text] [Related]
28. Hypofractionated whole breast irradiation for patients with large breasts: a randomized trial comparing prone and supine positions.
Mulliez T; Veldeman L; van Greveling A; Speleers B; Sadeghi S; Berwouts D; Decoster F; Vercauteren T; De Gersem W; Van den Broecke R; De Neve W
Radiother Oncol; 2013 Aug; 108(2):203-8. PubMed ID: 24044803
[TBL] [Abstract][Full Text] [Related]
29. Preliminary results of electron intraoperative therapy boost and hypofractionated external beam radiotherapy after breast-conserving surgery in premenopausal women.
Ivaldi GB; Leonardi MC; Orecchia R; Zerini D; Morra A; Galimberti V; Gatti G; Luini A; Veronesi P; Ciocca M; Sangalli C; Fodor C; Veronesi U
Int J Radiat Oncol Biol Phys; 2008 Oct; 72(2):485-93. PubMed ID: 18407434
[TBL] [Abstract][Full Text] [Related]
30. Long-term toxicity of an intraoperative radiotherapy boost using low energy X-rays during breast-conserving surgery.
Kraus-Tiefenbacher U; Bauer L; Scheda A; Fleckenstein K; Keller A; Herskind C; Steil V; Melchert F; Wenz F
Int J Radiat Oncol Biol Phys; 2006 Oct; 66(2):377-81. PubMed ID: 16887294
[TBL] [Abstract][Full Text] [Related]
31. Acute radiation dermatitis and pneumonitis in Japanese breast cancer patients with whole breast hypofractionated radiotherapy compared to conventional radiotherapy.
Osako T; Oguchi M; Kumada M; Nemoto K; Iwase T; Yamashita T
Jpn J Clin Oncol; 2008 May; 38(5):334-8. PubMed ID: 18417501
[TBL] [Abstract][Full Text] [Related]
32. [Accelerated partial breast irradiation: a concept to individualize treatment in breast cancer].
Belkacémi Y; Comet B; Hannoun-Levi JM; Villette S; Marsiglia H; Leblanc-Onfroy M; Delalande B; Azria D; Dubois JB
Cancer Radiother; 2007 Nov; 11(6-7):287-95. PubMed ID: 17977768
[TBL] [Abstract][Full Text] [Related]
33. Comparison of chronic toxicities between brachytherapy-based accelerated partial breast irradiation and whole breast irradiation using intensity modulated radiotherapy.
Wobb JL; Shah C; Jawad MS; Wallace M; Dilworth JT; Grills IS; Ye H; Chen PY
Breast; 2015 Dec; 24(6):739-44. PubMed ID: 26459227
[TBL] [Abstract][Full Text] [Related]
34. Hypofractionated and accelerated radiotherapy with subcutaneous amifostine cytoprotection as short adjuvant regimen after breast-conserving surgery: interim report.
Koukourakis MI; Tsoutsou PG; Abatzoglou IM; Sismanidou K; Giatromanolaki A; Sivridis E
Int J Radiat Oncol Biol Phys; 2009 Jul; 74(4):1173-80. PubMed ID: 19058920
[TBL] [Abstract][Full Text] [Related]
35. Irradiation in early-stage breast cancer: conventional whole-breast, accelerated partial-breast, and accelerated whole-breast strategies compared.
Mouw KW; Harris JR
Oncology (Williston Park); 2012 Sep; 26(9):820-30. PubMed ID: 23061336
[TBL] [Abstract][Full Text] [Related]
36. Predictors for clinical outcomes after accelerated partial breast intensity-modulated radiotherapy.
Reeder R; Carter DL; Howell K; Henkenberns P; Tallhamer M; Johnson T; Kercher J; Widner J; Kaske T; Paul D; Sedlacek S; Leonard CE
Int J Radiat Oncol Biol Phys; 2009 May; 74(1):92-7. PubMed ID: 18786783
[TBL] [Abstract][Full Text] [Related]
37. Ductal carcinoma in situ of the breast with close or focally involved margins following breast-conserving surgery: treatment with reexcision or radiotherapy with increased dosage.
Monteau A; Sigal-Zafrani B; Kirova YM; Fourchotte V; Bollet MA; Vincent-Salomon A; Asselain B; Salmon RJ; Fourquet A
Int J Radiat Oncol Biol Phys; 2009 Nov; 75(4):1021-8. PubMed ID: 19386441
[TBL] [Abstract][Full Text] [Related]
38. [Combined surgery and radiotherapy in the treatment of ductal carcinoma in situ of the breast: preliminary results of the Hungarian multicenter prospective randomised study].
Polgár C; Orosz Z; Kahán Z; Gábor G; Jani N; Cserni G; Hadijev J; Kulka J; Sulyok Z; Boross G; Lázár G; László Z; Diczházi C; Udvarhelyi N; Szabó E; Péntek Z; Major T; Fodor J
Magy Onkol; 2008 Sep; 52(3):269-77. PubMed ID: 18845497
[TBL] [Abstract][Full Text] [Related]
39. Clinical outcome analysis in "high-risk" versus "low-risk" patients eligible for national surgical adjuvant breast and bowel B-39/radiation therapy oncology group 0413 trial: five-year results.
Patel RR; Christensen ME; Hodge CW; Adkison JB; Das RK
Int J Radiat Oncol Biol Phys; 2008 Mar; 70(4):970-3. PubMed ID: 18313521
[TBL] [Abstract][Full Text] [Related]
40. Breast-conserving treatment in the elderly: long-term results of adjuvant hypofractionated and normofractionated radiotherapy.
Kirova YM; Campana F; Savignoni A; Laki F; Muresan M; Dendale R; Bollet MA; Salmon RJ; Fourquet A;
Int J Radiat Oncol Biol Phys; 2009 Sep; 75(1):76-81. PubMed ID: 19168297
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
